VERACYTE, INC. Income Tax Expense
VERACYTE, INC. (VCYT) reported Income Tax Expense of $1.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-31
- VERACYTE, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $1.03M, a 53.68% decline year-over-year.
- VERACYTE, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $1.27M, a 232.55% increase year-over-year.
- VERACYTE, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was -$515.00K.
- VERACYTE, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$248.00K, a 114.65% decline year-over-year.
- VERACYTE, INC. income tax expense (benefit) for fiscal 2025 was $1.85M, a 15.07% increase from fiscal 2024.
- VERACYTE, INC. income tax expense (benefit) for fiscal 2024 was $1.61M.
- VERACYTE, INC. income tax expense (benefit) for fiscal 2023 was -$2.21M, a 1760.15% decline from fiscal 2022.
- VERACYTE, INC. income tax expense (benefit) for fiscal 2022 was $133.00K.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-07-31 | $2.30M 10-Q · filed 2026-07-31 | $1.78M derived: sum of 3 quarters · filed 2026-07-31 | $1.54M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-06 | $752.00K derived: sum of 2 quarters · filed 2026-05-06 | $504.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.73M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | -$515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$763.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.47M derived: sum of 3 quarters · filed 2026-07-31 | $1.85M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$248.00K 10-Q · filed 2025-11-05 | $1.98M derived: sum of 2 quarters · filed 2026-07-31 | $2.36M 10-Q · filed 2025-11-05 | $693.00K derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-30 | $2.23M 10-Q · filed 2026-07-31 | $2.61M 10-Q · filed 2026-07-31 | $941.00K derived: sum of 3 quarters · filed 2026-07-31 | $2.63M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-31 | $381.00K 10-Q · filed 2026-05-06 | -$1.29M derived: sum of 2 quarters · filed 2026-05-06 | $404.00K derived: sum of 3 quarters · filed 2026-05-06 | $2.03M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.65M derived: sum of 3 quarters · filed 2026-02-26 | $1.61M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.69M 10-Q · filed 2025-11-05 | $3.32M derived: sum of 2 quarters · filed 2025-11-05 | $3.28M 10-Q · filed 2025-11-05 | $1.10M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $1.63M 10-Q · filed 2025-08-07 | $1.58M 10-Q · filed 2025-08-07 | -$596.00K derived: sum of 3 quarters · filed 2026-02-26 | -$750.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$44.00K 10-Q · filed 2025-05-08 | -$2.22M derived: sum of 2 quarters · filed 2026-02-26 | -$2.38M derived: sum of 3 quarters · filed 2026-02-26 | -$2.25M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.33M derived: sum of 2 quarters · filed 2026-02-26 | -$2.21M derived: sum of 3 quarters · filed 2026-02-26 | -$2.21M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$154.00K 10-Q · filed 2024-11-07 | -$29.00K derived: sum of 2 quarters · filed 2024-11-07 | -$29.00K 10-Q · filed 2024-11-07 | $374.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $125.00K 10-Q · filed 2024-08-07 | $125.00K 10-Q · filed 2024-08-07 | $528.00K derived: sum of 3 quarters · filed 2025-02-28 | $376.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $403.00K derived: sum of 2 quarters · filed 2025-02-28 | $251.00K derived: sum of 3 quarters · filed 2025-02-28 | $136.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $251.00K derived: sum of 2 quarters · filed 2025-02-28 | $136.00K derived: sum of 3 quarters · filed 2025-02-28 | $133.00K 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$152.00K 10-Q · filed 2023-11-08 | -$267.00K derived: sum of 2 quarters · filed 2023-11-08 | -$270.00K 10-Q · filed 2023-11-08 | -$1.06M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | -$115.00K 10-Q · filed 2023-08-09 | -$118.00K 10-Q · filed 2023-08-09 | -$907.00K derived: sum of 3 quarters · filed 2024-02-29 | -$2.26M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | -$3.00K 10-Q · filed 2023-05-05 | -$792.00K derived: sum of 2 quarters · filed 2024-02-29 | -$2.14M derived: sum of 3 quarters · filed 2024-02-29 | -$2.29M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | -$789.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$2.14M derived: sum of 2 quarters · filed 2024-02-29 | -$2.29M derived: sum of 3 quarters · filed 2024-02-29 | -$6.09M 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$1.35M 10-Q · filed 2022-11-03 | -$1.50M derived: sum of 2 quarters · filed 2022-11-03 | -$5.30M 10-Q · filed 2022-11-03 | -$5.30M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$152.00K 10-Q · filed 2022-08-03 | -$3.95M 10-Q · filed 2022-08-03 | -$3.95M derived: sum of 3 quarters · filed 2023-03-01 | -$3.95M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$3.79M 10-Q · filed 2022-05-04 | $3.79M 10-Q · filed 2021-05-10 | -$3.79M derived: sum of 2 quarters · filed 2023-03-01 | -$3.79M derived: sum of 3 quarters · filed 2023-03-01 | -$3.79M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $0.00 10-Q · filed 2020-11-02 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-22 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-25 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |